What one share of Yubo International Biotech Limited holds
We are a U.S. holding company primarily operating through our wholly owned subsidiary, Platinum International Biotech Co., Ltd., a company organized under the laws of the Cayman Islands (“Platinum”).
Yubo International Biotech Limited’s numbers from its SEC filings, divided by its shares. Results cover the last 12 months to 2026-06-30; the balance sheet is as of 2026-06-30.
| Sales | $0.00 |
|---|---|
| Profit | −$0.01 |
| Cash and investments | $0.00 |
| Book value | −$0.02 |
Per share by fiscal year
| Year | Sales | Profit | Capex | Free cash | Dividends | Book value |
|---|---|---|---|---|---|---|
| 2011 | — | −$0.09 | — | — | — | −$0.59 |
| 2012 | — | −$0.07 | — | — | — | −$0.68 |
| 2013 | — | −$0.09 | — | — | — | −$0.77 |
| 2014 | — | −$0.09 | — | — | — | −$0.86 |
| 2015 | — | −$0.10 | — | — | — | −$0.96 |
| 2016 | — | −$0.11 | — | — | — | −$1.07 |
| 2017 | — | −$0.19 | — | — | — | −$1.16 |
| 2018 | — | −$0.12 | — | — | — | −$1.29 |
| 2019 | — | −$0.13 | — | — | — | −$1.41 |
| 2020 | — | −$0.11 | — | — | — | −$1.52 |
| 2023 | — | −$0.10 | — | — | — | −$0.15 |
| 2024 | — | −$0.01 | — | — | — | −$0.03 |
| 2025 | $0.00 | −$0.01 | — | — | — | −$0.01 |
Common questions about Yubo International Biotech Limited
How much does one share of Yubo International Biotech Limited earn?
Over the last 12 months, Yubo International Biotech Limited lost $0.01 for each share on $0.00 of sales.
Does Yubo International Biotech Limited pay a dividend?
Yubo International Biotech Limited didn’t pay a dividend over the last 12 months, according to its SEC filings.
What is Yubo International Biotech Limited’s book value per share?
Yubo International Biotech Limited’s book value is negative (−$0.02 per share): it owes more than everything it owns is recorded at, often after years of buying back its own shares, as of June 30, 2026.
How much cash and debt does each share of Yubo International Biotech Limited have?
Each share of Yubo International Biotech Limited has $0.00 of cash and investments, as of June 30, 2026.
Has Yubo International Biotech Limited bought back shares?
Yubo International Biotech Limited’s share count rose about 11325% from 2011 to 2025. That dilution means each share owns a smaller slice of the company.
From its SEC filings. For education only, not investment advice. New to these words? See the StockSlicer glossary.